Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer
NEJM Evidence · 27.06.2023 · 2 (7)
DOI: 10.1056/evidoa2200309 ↗Kurz gefasst
Fachartikel in der Zeitschrift NEJM Evidence, erschienen am 27.06.2023. Verfasst von K C Allen Chan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
- Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
- State Key Laboratory of Translational Oncology, Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
- Centre for Novostics, The Chinese University of Hong Kong, Hong Kong Science and Technology Park, Pak Shek Kok, New Territories, Hong Kong SAR, China.
- Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
Zitieren
APA
Chan, K. C. A., Lam, W. K. J., King, A., Lin, V. S., Lee, P. P. H., Zee, B. C. Y., Chan, S. L., Tse, I. O. L., Tsang, A. F. C., Li, M. Z. J., Jiang, P., Ai, Q. Y. H., Poon, D. M. C., Au, K. H., Hui, E. P., Ma, B. B. Y., Van Hasselt, A. C., Chan, A. T. C., Woo, J. K. S., & Lo, Y. M. D. (2023). Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer. NEJM Evidence, 2(7). https://doi.org/10.1056/evidoa2200309
Vancouver
Chan KCA, Lam WKJ, King A, Lin VS, Lee PPH, Zee BCY, et al. Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer. NEJM Evidence. 2023;2(7). doi:10.1056/evidoa2200309
BibTeX
@article{Chan2023,
author = {Chan, K C Allen and Lam, W K Jacky and King, Ann and Lin, Vivien S and Lee, Patrick P H and Zee, Benny C Y and Chan, Stephen L and Tse, Irene O L and Tsang, Amy F C and Li, Maggie Z J and Jiang, Peiyong and Ai, Qi Yong H and Poon, Darren M C and Au, K H and Hui, Edwin P and Ma, Brigette B Y and Van Hasselt, Andrew C and Chan, Anthony T C and Woo, John K S and Lo, Y M Dennis},
title = {Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer},
journal = {NEJM Evidence},
year = {2023},
volume = {2},
number = {7},
doi = {10.1056/evidoa2200309}
}
EUVIMED